Related Experiment Video
Updated: Feb 5, 2026
02:34
Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms
Published on: May 10, 2024
1.9K
[Surfactant protein A gene polymorphisms in chronic obstructive pulmonary disease]
Jun-gang Xie1, Yong-jian Xu, Zhen-xiang Zhang
1Department of Respiratory Medicine, Tongji Hospital of Tongji Medical College, Huazhong Science and Technology University, Wuhan, Huibei, 430030 PR China.
Summary
Genetic variations in surfactant protein A (SPA) are linked to chronic obstructive pulmonary disease (COPD) susceptibility. This study found specific SPA gene polymorphisms associated with COPD development in the Chinese Han population.
Area of Science:
- Pulmonary Medicine
- Genetics
- Molecular Biology
Context:
- Chronic obstructive pulmonary disease (COPD) is a major global health concern.
- Genetic factors play a role in COPD susceptibility.
- Surfactant protein A (SPA) is involved in lung immune defense.
Purpose:
- To determine if genetic variations in the surfactant protein A (SPA) gene are associated with the risk of developing chronic obstructive pulmonary disease (COPD).
Summary:
- This study analyzed SPA gene polymorphisms in 88 COPD patients and 87 healthy smokers using polymerase chain reaction and restriction fragment length polymorphism analysis.
- Significant differences in the frequencies of specific SPA gene genotypes (+186 locus) and alleles were observed between COPD patients and controls (P<0.05).
- No significant association was found for polymorphisms at the +655 and +667 loci of the SPA gene.
Impact:
- Identifies specific SPA gene polymorphisms as potential biomarkers for COPD risk in the Chinese Han population.
- Highlights the role of genetic factors in COPD pathogenesis.
- Provides insights for future research into targeted COPD prevention and treatment strategies based on genetic profiles.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease
2.6K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.5K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.5K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.8K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.2K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.2K
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.2K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.2K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.7K